5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.25▼ | 1.24▼ | 1.23▲ | 1.23▼ | 1.33▼ |
MA10 | 1.24▼ | 1.24▼ | 1.26▼ | 1.31▼ | 1.19▲ |
MA20 | 1.27▼ | 1.31▼ | 1.33▼ | 1.31▼ | 1.14▲ |
MA50 | 1.35▼ | 1.35▼ | 1.32▼ | 1.15▲ | 1.28▼ |
MA100 | 1.34▼ | 1.30▼ | 1.31▼ | 1.13▲ | N/A |
MA200 | 1.28▼ | 1.27▼ | 1.19▲ | 1.22▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | -0.006▼ | -0.015▼ | -0.026▼ | 0.039▲ |
RSI | 37.282▼ | 37.829▼ | 37.224▼ | 45.579▼ | 50.085▲ |
STOCH | 60.000 | 29.877 | 13.762▼ | 18.341▼ | 74.503 |
WILL %R | -66.667 | -81.250▼ | -86.667▼ | -95.833▼ | -40.511 |
CCI | -0.485 | -46.698 | -44.561 | -94.696 | 59.799 |
MA | $MIRA Price Crossed Below MA(200) | Set Alert |
Thursday, May 15, 2025 09:19 AM
MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic cannabinoid analog for the treatment of ...
|
Thursday, May 08, 2025 12:16 AM
Under the terms, MIRA will acquire SKNY through a stock exchange, whereby SKNY shareholders will receive shares of MIRA common stock at a valuation determined by an independent third-party firm.
|
Monday, May 05, 2025 11:27 PM
MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic cannabinoid analog for the treatment of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 1.23 | 1.28 | 1.20 | 1.21 | 79,484 |
12/06/25 | 1.21 | 1.26 | 1.21 | 1.24 | 68,290 |
11/06/25 | 1.25 | 1.25 | 1.2089 | 1.21 | 64,477 |
10/06/25 | 1.215 | 1.23 | 1.205 | 1.205 | 169,066 |
09/06/25 | 1.40 | 1.42 | 1.28 | 1.29 | 316,058 |
06/06/25 | 1.36 | 1.43 | 1.36 | 1.40 | 140,057 |
05/06/25 | 1.38 | 1.43 | 1.37 | 1.37 | 69,701 |
04/06/25 | 1.38 | 1.43 | 1.343 | 1.40 | 128,400 |
03/06/25 | 1.39 | 1.44 | 1.32 | 1.38 | 195,154 |
02/06/25 | 1.32 | 1.40 | 1.30 | 1.39 | 171,098 |
|
|
||||
|
|
||||
|
|